MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
June 05 2023 - 7:30AM
MiNK Therapeutics (Nasdaq: INKT), a clinical-stage
biopharmaceutical company specializing in the discovery,
development, and commercialization of allogeneic, off-the-shelf,
invariant natural killer T (iNKT) cell therapies to treat cancer
and other immune-mediated diseases, today announced that its
virtual-only Annual Meeting of Shareholders will be held on
Tuesday, June 13, 2023, at 10:30 AM ET.
To participate in the Annual Shareholders Meeting, shareholders
should
visit https://east.virtualshareholdermeeting.com/vsm/web?pvskey=INKT2023
and enter the 16-digit control number found in their proxy
materials. Guests may participate in a listen-only mode. No control
number is required for guests.
Webcast Information:
Date: Tuesday June 13th, 2023
Time: 10:30 AM ET
A live webcast and replay will be accessible from the Company's
website
at https://investor.minktherapeutics.com/events-and-presentations
and
at https://east.virtualshareholdermeeting.com/vsm/web?pvskey=INKT2023.
About MiNK Therapeutics
MiNK Therapeutics is a clinical-stage biopharmaceutical company
pioneering the discovery, development, and commercialization of
allogeneic invariant natural killer T (iNKT) cell therapies to
treat cancer and other immune-mediated diseases. MiNK is advancing
a pipeline of both native and next generation engineered iNKT
programs, with a platform designed to facilitate scalable and
reproducible manufacturing for off-the-shelf delivery. The company
is headquartered in New York, NY. For more information, visit
https://minktherapeutics.com/. Follow us on Twitter @MiNK_iNKT.
Contact
Alexa Buffa781-674-4428communications@minktherapeutics.com
Investor Relations:Zack
Armen917-362-1370investor@minktherapeutics.com
MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
From Apr 2024 to May 2024
MiNK Therapeutics (NASDAQ:INKT)
Historical Stock Chart
From May 2023 to May 2024